Adhering to current clinical guidance supports evidence-based assessment, informs decision-making, and helps manage breakouts and flare-ups in patients living with acne vulgaris and rosacea. Ongoing review of recommendations and guidance enables clinicians to improve evaluation and management, which supports better patient outcomes.
Today's rundown features clinical guidelines and a consensus statement, all published since April 2021. The guidance is grouped based on skin condition. The most recent document was the European Dermatology Forum’s guideline, Treatment of Acne, which was published last month.
The Latest Acne Vulgaris Guidelines
- Treatment of Acne
- European Dermatology Forum (EDF), March 2026
- Management of Acne Vulgaris
- American Academy of Dermatology (AAD), January 2024
- Acne Vulgaris: Management
- British Association of Dermatologists (BAD), National Institute for Health and Care Excellence (NICE), December 2023
The Latest Acne Rosacea Clinical Guidance
- Rosacea Treatment Algorithm
- National Rosacea Society (NRS), March 2025
- Management of People with Rosacea
- British Association of Dermatologists (BAD), October 2021
Check out other clinical guidelines and sign up for alerts to stay informed on the latest published guidelines and insights.